DILIC
RGEN icon

Dai-ichi Life Insurance Company’s Repligen RGEN Stock Holding History

Dai-ichi Life Insurance Company’s Portfolio RGEN Stock Details RGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-4,224
Closed -$711K – 493
2023
Q1 		$711K Hold
4,224
– – 0.02% 409
2022
Q4 		$715K Buy
+4,224
New +$766K 0.02% 414

Other funds holding RGEN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Dai-ichi Life Insurance Company's RGEN Position: Q2 2023 in Review

Dai-ichi Life Insurance Company sold out of Repligen (RGEN) in Q2 2023, closing a stake of 4,224 shares — an estimated $711K sold.

Dai-ichi Life Insurance Company first reported a position in RGEN in Q4 2022 and held it in 2 quarters. The position peaked at $715K in Q4 2022. 448 funds tracked by Wall St. Rank hold RGEN as of Q2 2023.

  • Dai-ichi Life Insurance Company reported no remaining Repligen position as of Q2 2023 after selling out during the quarter.
  • Dai-ichi Life Insurance Company sold 4,224 Repligen shares in Q2 2023, an estimated $711K.
  • Dai-ichi Life Insurance Company first reported a position in Repligen in Q4 2022 and held it in 2 quarters.
  • Dai-ichi Life Insurance Company's Repligen position peaked at $715K in Q4 2022.
  • 448 funds tracked by Wall St. Rank held Repligen as of Q2 2023.

Based on Dai-ichi Life Insurance Company's 13F filing for Q2 2023, filed 11 Aug 2023.